NCAM1 and brain neoplasm: NCAM1 (CD56) was subsequently detected in various tumors of neuroectodermal origin, such as neuroblastoma; rhabdomyosarcoma; various brain tumors; and, notably, small cell lung carcinoma [6,7,8].